Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan · Delayed Price · Currency is JPY 5,777.00
+77.00 (1.35%)
Sep 10, 2026, 3:30 PM JST
Kobayashi Pharmaceutical Market Cap
Kobayashi Pharmaceutical has a market cap or net worth of 429.45 billion as of September 10, 2026. Its market cap has increased by 4.66% in one year.
Market Cap
429.45B
Enterprise Value
372.86B
Revenue
167.47B
Ranking
n/a
PE Ratio
264.28
Stock Price
5,777.00
ChartMarket Cap Chart
Since August 17, 1999, Kobayashi Pharmaceutical's market cap has increased from 245.70B to 429.45B, an increase of 74.79%. That is a compound annual growth rate of 2.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 429.45B | 6.43% |
| Dec 30, 2025 | 403.51B | -12.87% |
| Dec 30, 2024 | 463.13B | -8.08% |
| Dec 29, 2023 | 503.84B | -22.52% |
| Dec 30, 2022 | 650.29B | -7.68% |
| Dec 30, 2021 | 704.43B | -28.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unicharm | 1.66T |
| Shiseido Company | 1.34T |
| Rohto Pharmaceutical | 649.99B |
| Lion Corporation | 500.41B |
| MTG Co., Ltd. | 323.90B |
| KOSE Holdings | 320.64B |
| Pola Orbis Holdings | 297.40B |
| Pigeon | 235.08B |